Loading clinical trials...
Loading clinical trials...
Open-label, multicenter study in adults with Primary Biliary Cirrhosis (PBC) designed to evaluate the long-term safety and tolerability of daily dosing with LUM001.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Mirum Pharmaceuticals, Inc.
NCT04526665 · Primary Biliary Cirrhosis
NCT03301506 · Primary Biliary Cirrhosis
NCT03743272 · Liver Diseases, Primary Biliary Cirrhosis, and more
NCT02846896 · Primary Biliary Cirrhosis
NCT03112681 · Primary Biliary Cirrhosis
Scripps Clinic
La Jolla, California
University of California at Davis
Sacramento, California
University of Miami
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions